share_log

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

Perspective Therapeutics 和其他三隻價格低於 1 美元的股票業
Benzinga ·  2023/12/19 21:29

The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週一收盤小幅走高。當內部人士買入或賣出股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將其視爲其整體投資或交易決策中的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。

Tharimmune

Tharmunmune

  • The Trade: Tharimmune, Inc. (NASDAQ:THAR) CEO Randy Milby acquired a total of 29,000 shares an average price of $0.50. To acquire these shares, it cost around $14,587.
  • What's Happening: Tharimmune recently announced topline data with TH104, its lead candidate for moderate-to-severe pruritus in chronic liver disease patients.
  • What Tharimmune Does: Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases.
  • 交易：Tharimmune, Inc.（納斯達克股票代碼：THAR）首席執行官蘭迪·米爾比 共收購了 29,000 股股票 平均價格爲0.50美元。收購這些股票的成本約爲14,587美元。
  • 發生了什麼：Tharimmune 最近公佈了 TH104 的頭條數據，是慢性肝病患者中度至重度瘙癢症的主要候選藥物。
  • Tharimmune 的作用：Tharimmune Inc. 是一家生物技術公司，正在開發針對罕見免疫、炎症和腫瘤疾病的候選治療產品組合。

Perspective Therapeutics

透視療法

  • The Trade: Perspective Therapeutics, Inc. (NASDAQ:CATX) Director Lori A Woods acquired a total of 185,200 shares at an average price of $0.27. To acquire these shares, it cost around $49,989.
  • What's Happening: Perspective Therapeutics recently announced it agreed to fully divest its brachytherapy business.
  • What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.
  • 交易：Perspective Therapeutics, Inc.（納斯達克股票代碼：CATX）董事洛裏·伍茲 共收購了 185,200 股股票 平均價格爲0.27美元。收購這些股票的成本約爲49,989美元。
  • 發生了什麼：Perspective Therapeutics最近宣佈，它同意完全剝離其近距離放射治療業務。
  • Perspective Therapeutics做什麼：Perspective Therapeutics Inc是一家醫療技術和放射性藥物公司，致力於開創全身癌症的各種治療應用。

Check This Out: Aware And 3 Other Stocks Under $2 Insiders Are Buying

看看這個： Aware 還有其他 3 只低於 2 美元的股票業內人士正在買入

SHF Holdings

SHF Holdings

  • The Trade: SHF Holdings, Inc. (NASDAQ:SHFS) CEO Sundie Seefried acquired a total of 24,700 shares at an average price of $0.96. The insider spent around $23,737 to buy those shares. The company's Director also bought 15,000 shares of the company.
  • What's Happening: On Nov. 14, SHF Hldgs posted a loss for the third quarter.
  • What SHF Holdings Does: SHF Holdings Inc is a financial services provider to cannabis-related businesses.
  • 交易：SHF Holdings, Inc.（納斯達克股票代碼：SHFS）首席執行官桑迪·塞弗裏德 共收購了 24,700 股股票 平均價格爲0.96美元。內幕人士花費了大約23,737美元購買了這些股票。該公司的董事還購買了公司的15,000股股票。
  • 發生了什麼：11月14日，SHF Hldgs公佈了第三季度的虧損。
  • SHF Holdings做什麼：SHF Holdings Inc是大麻相關企業的金融服務提供商。

Dalrada Financial

達爾拉達金融

  • The Trade: Dalrada Financial Corporation (OTC:DFCO) CEO Brian Bonar acquired a total of 9,000 shares at an average price of $0.29. The insider spent around $2,616 to buy those shares.
  • What's Happening: The company's stock jumped 26% over the past six months.
  • What Dalrada Financial Does: Dalrada Financial Corp is a United States-based company engaged in providing financial, insurance, benefit, and business process outsourcing products and services to companies.
  • 交易：達拉達金融公司（場外交易代碼：DFCO）首席執行官布萊恩·博納 共收購9,000股股份 平均價格爲0.29美元。內幕人士花費了約2616美元購買這些股票。
  • 發生了什麼：該公司的股票在過去六個月中上漲了26％。
  • Dalrada Financial做什麼：Dalrada Financial Corp是一家總部位於美國的公司，致力於爲公司提供財務、保險、福利和業務流程外包產品和服務。

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論